[at Motley Fool] – Pfizer’s boomed in 2013, and with the patent cliff’s worries beginning to subside, the stock could be ready to keep rolling in the new year.
Read more on this.
Pfizer Inc. (PFE), valued at $206.62B, began … [visit site to read more]
Similar posts:- Stock Update: Morgan Stanley (NYSE:MS) – Denmark’s ISS aims for March 2014 stock market debut-sources
- Pfizer Inc. (NYSE:PFE) – September 2014 Options Now Available For Pfizer (PFE)
- Pfizer Inc. (NYSE:PFE) | Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014
